Eton Pharmaceuticals ETON Revenue Breakdown

NASDAQ ETON
$50.02 +0.72 (+1.46%)
At close: Oct 22, 2026 · 4:00 PM EDT
Annual revenue breakdowns for Eton Pharmaceuticals, fiscal 2019 to 2025, as reported in its filings.
Annual history

Eton Pharmaceuticals Revenue by Product & Service

Years FY 2019–2025
Lines 2
FY 2025 Total $79.95M

Product Sales & Royalties was Eton Pharmaceuticals’s largest product and service line in fiscal 2025, bringing in $76.66M of $79.95M (96%).

Eton Pharmaceuticals revenue by product and service, fiscal 2019 to 2025
Product and Service FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Product Sales & Royalties $11.25M $26.14M $38.51M $76.66M
License $10.00M $5.50M $500.00K $3.29M
Total $21.25M $31.64M $39.01M $79.95M
Totals include 2 discontinued lines from earlier reporting.

Eton Pharmaceuticals revenue by product and service: what the figures show

Eton Pharmaceuticals brought in $79.95M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 104.9% from $39.01M in fiscal 2024. Product Sales & Royalties was the largest at $76.66M (95.9%), ahead of License at $3.29M (4.1%).

Compared with fiscal 2024, License grew 557.2% to $3.29M and Product Sales & Royalties grew 99.1% to $76.66M. From fiscal 2022 to 2025, combined revenue from these lines grew from $21.25M to $79.95M, a compound annual growth rate of 55.5%. Product Sales & Royalties' share of the total rose from 52.9% to 95.9%.

Questions

Eton Pharmaceuticals Revenue Breakdown FAQ

How does Eton Pharmaceuticals make money?

Eton Pharmaceuticals (ETON) reports its revenue by product and service. In fiscal 2025, Product Sales & Royalties was its largest product and service line, bringing in $76.66M (95.9% of the total), followed by License at $3.29M (4.1%).

What is Eton Pharmaceuticals' largest product and service line?

Product Sales & Royalties was Eton Pharmaceuticals' largest product and service line in fiscal 2025, bringing in $76.66M, or 95.9% of the $79.95M total across its two product and service lines.

Which Eton Pharmaceuticals product and service line is growing the fastest?

License grew faster than Product Sales & Royalties in fiscal 2025, up 557.2% from $500.00K to $3.29M. Product Sales & Royalties grew 99.1% to $76.66M.

Where does this revenue breakdown data come from?

Every figure comes from Eton Pharmaceuticals' annual financial filings, as reported. Each line keeps the name Eton Pharmaceuticals gives it, and years follow its fiscal calendar.

How far back does Eton Pharmaceuticals' revenue breakdown go?

Eton Pharmaceuticals' revenue by product and service goes back to fiscal 2019, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.